Related Experiment Video
Updated: Jun 24, 2026
08:46
T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
Published on: January 26, 2024
T4 phages against Escherichia coli diarrhea: potential and problems
Emmanuel Denou1, Anne Bruttin, Caroline Barretto
1Nestlé Research Center, Nestec Ltd, Lausanne 26, Switzerland.
Virology
|April 3, 2009
Summary
A phage cocktail of T4 coliphages effectively targets E. coli diarrhea without harming gut microbiota. These phages are safe, showing no adverse effects or antibody development in mice, and demonstrate strain-specific efficacy.
Area of Science:
- Microbiology
- Genomics
- Gastroenterology
Background:
- Bacteriophage therapy offers a promising alternative to antibiotics for bacterial infections.
- Escherichia coli (E. coli) diarrhea remains a significant global health concern, necessitating novel therapeutic strategies.
- Developing targeted phage therapies requires understanding phage-host interactions and genomic diversity.
Purpose of the Study:
- To rationally design a phage cocktail for treating E. coli diarrhea.
- To evaluate the safety and efficacy of orally administered T4 coliphages in vivo.
- To analyze the genomic characteristics of T4 phages for cocktail development.
Main Methods:
- In vitro and in vivo experiments were conducted.
- Comparative phage genomics and bioinformatic analyses were employed.
- Murine models were used to assess gut microbiota impact, phage distribution, and safety.
Main Results:
- Orally administered T4 coliphages showed no negative impact on murine gut microbiota.
- High phage titers were detected in the murine cecum and colon, with no systemic dissemination.
- No adverse effects or anti-T4 antibody development were observed after one month of phage exposure.
- Genomic analysis revealed T4 phages within subgroups are closely related, with variability in tail fiber genes not correlating with host range.
- Phage cocktails comprising 10 and 16 T4 isolates were necessary to cover a significant portion of pathogenic E. coli strains.
Conclusions:
- T4 coliphages are safe and effective for oral administration in a murine model.
- Phage cocktails are essential due to the species- and strain-specificity of T4 phages against pathogenic E. coli.
- This study provides a foundation for developing targeted phage-based therapies against E. coli diarrhea.
More Related Videos
Related Concept Videos
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
01:20Viral Replication: Lytic Cycle
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
00:43Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:26DNA Bacteriophages
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...